Nurix Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Cash & Equivalents	246.96	110	54.63	64.47	80.51
Short-Term Investments	345.98	499.59	233.28	244.67	215.21
Cash & Short-Term Investments	592.94	609.58	287.91	309.14	295.72
Cash Growth	-2.73%	111.73%	-6.87%	4.54%	5.18%
Accounts Receivable	-	-	-	-	6
Other Receivables	-	-	-	-	0.2
Total Trade Receivables	-	-	-	-	6.2
Other Current Assets	13.88	9.8	7.6	9.31	9.19
Total Current Assets	606.82	619.39	295.5	318.45	311.12
Net Property, Plant & Equipment	73.01	45.9	47.95	29.51	25.35
Long-Term Investments	-	-	7.42	63.88	137.19
Other Long-Term Assets	8.31	4.06	4.72	4.92	3.12
Total Assets	688.14	669.34	355.6	416.76	476.77
Accounts Payable	11.22	11.48	6.4	5.06	6.65
Accrued Expenses	54.85	37.99	24.97	22.43	14.55
Current Portion of Leases	2.82	8.01	7.49	5.53	3.85
Unearned Revenue	17.58	38.36	48.1	37.63	41.21
Total Current Liabilities	86.47	95.85	86.96	70.66	66.26
Long-Term Leases	52.91	20.29	23.13	6.43	9.19
Other Long-Term Liabilities	10.01	26.21	45.02	35.97	59.02
Total Long-Term Liabilities	62.92	46.5	68.15	42.41	68.21
Total Liabilities	149.39	142.35	155.11	113.06	134.47
Common Stock	0.1	0.08	0.05	0.05	0.05
Additional Paid-in Capital	1,542	1,266	746.3	709.22	563.76
Accumulated Other Comprehensive Income	0.11	0.15	-0.66	-4.32	-0.61
Retained Earnings	-1,003	-738.77	-545.2	-401.25	-220.89
Shareholders' Equity	538.75	526.99	200.49	303.7	342.3
Total Liabilities & Equity	688.14	669.34	355.6	416.76	476.77
Total Debt	55.73	28.3	30.61	11.96	13.04
Net Cash (Debt)	537.21	581.28	257.29	297.18	282.68
Net Cash Growth	-7.58%	125.92%	-13.42%	5.13%	0.55%
Net Cash Per Share	6.20	8.66	4.74	6.11	6.59
Book Value	538.75	526.99	200.49	303.7	342.3
Book Value Per Share	6.22	7.85	3.69	6.25	7.98
Tangible Book Value	538.75	526.99	200.49	303.7	342.3
Tangible Book Value Per Share	6.22	7.85	3.69	6.25	7.98

Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q